Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SANOFI : Deutsche Bank reaffirms its Sell rating

12/03/2021 | 06:34am EST

The analyst from Deutsche Bank, Emmanuel Papadakis, maintains his advice to sell. The target price remains set at EUR 80.


ę MarketScreener with dpa-AFX Analyser 2021
All news about SANOFI
01/24SANOFI : Second positive Phase 3 Dupixent« (dupilumab) trial confirms significant improvem..
PU
01/21SANOFI : Early redemption / Cancellation / Delisting
PU
01/20Exclusive-Polish drug maker Polpharma working on bid for Advent's Zentiva - sources
RE
01/19Regeneron Says FDA to Review Libtayo/Chemotherapy Combo in First-Line NSCLC Treatment
DJ
01/19Sanofi, Regeneron Say Dupixent Significantly Reduces Itching in Prurigo Nodularis Patie..
MT
01/19Sanofi-Regeneron's Dermatitis Drug Lowers Itch, Skin Lesions In Late-Stage Trial
MT
01/19Sanofi Announces Second Positive Phase 3 Dupixent« Trial Confirms Significant Improveme..
CI
01/17Factbox-GSK's consumer healthcare business coveted by Unilever
RE
01/15Factbox-GSK's consumer health business
RE
01/15GSK rejects 50-billion-pound Unilever offer for consumer assets
RE
More news
Analyst Recommendations on SANOFI
More recommendations
Financials
Sales 2021 37 786 M 42 615 M 42 615 M
Net income 2021 6 139 M 6 924 M 6 924 M
Net Debt 2021 9 925 M 11 193 M 11 193 M
P/E ratio 2021 18,2x
Yield 2021 3,73%
Capitalization 111 B 126 B 125 B
EV / Sales 2021 3,20x
EV / Sales 2022 2,93x
Nbr of Employees 99 412
Free-Float -
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 88,52 €
Average target price 107,27 €
Spread / Average Target 21,2%
EPS Revisions
Managers and Directors
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Director
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capi. (M$)
SANOFI-0.07%125 716
JOHNSON & JOHNSON-4.73%429 034
ROCHE HOLDING AG-9.06%304 714
PFIZER, INC.-12.72%289 287
ABBVIE INC.-2.39%233 643
ELI LILLY AND COMPANY-12.00%217 963